Autopoiesis Sciences: Seed

The business

Autopoiesis Sciences is building an autonomous AI scientist to support research workflows. Its tools are intended to help researchers move from questions and evidence toward experiments and findings, applying AI to work that currently requires extensive manual investigation. The company is developing the platform for scientific users who need to explore complex problems and accelerate discovery.

Funding history

Oct 6, 2026Seed · This round$11M

Sources

Autopoiesis Sciences lands $11M seed to build autonomous AI scientist | Dealroom Newsdealroom.co · Oct 6, 2026

Similar rounds

All Biotech rounds →

WhiteLab Genomics

WhiteLab Genomics uses AI to design genetic medicines and develop bio-assets for cell, RNA and DNA therapies.

$26MSeries B · Oct 6, 2026

Sensible Biotechnologies

A platform for designing and manufacturing naturally modified mRNA medicines.

$47MSeries A · Oct 6, 2026

Aventix

Aventix builds sensor-based analytical instruments for laboratories. Its first product, Scarlett 01, measures liquid volumes across microplate wells without touching the sample, helping R&D teams check dispensing quality and catch volume variation before it affects assay results.

€1.2MPre-seed · Sep 30, 2026

AnaCardio

AnaCardio is a clinical-stage biopharmaceutical company developing medicines intended to improve heart muscle function in people with heart failure.

€62.5MSeries B · Sep 30, 2026

The business

Funding history

Sources

Similar rounds

Related